These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 22157436)

  • 21. Cerebral Palsy: Current Opinions on Definition, Epidemiology, Risk Factors, Classification and Treatment Options.
    Sadowska M; Sarecka-Hujar B; Kopyta I
    Neuropsychiatr Dis Treat; 2020; 16():1505-1518. PubMed ID: 32606703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Injection of high dose botulinum-toxin A leads to impaired skeletal muscle function and damage of the fibrilar and non-fibrilar structures.
    Pingel J; Nielsen MS; Lauridsen T; Rix K; Bech M; Alkjaer T; Andersen IT; Nielsen JB; Feidenhansl R
    Sci Rep; 2017 Nov; 7(1):14746. PubMed ID: 29116170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Botulinum toxin injection causes hyper-reflexia and increased muscle stiffness of the triceps surae muscle in the rat.
    Pingel J; Wienecke J; Lorentzen J; Nielsen JB
    J Neurophysiol; 2016 Dec; 116(6):2615-2623. PubMed ID: 27628204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum Toxin Type A Injection for Spastic Equinovarus Foot in Children with Spastic Cerebral Palsy: Effects on Gait and Foot Pressure Distribution.
    Choi JY; Jung S; Rha DW; Park ES
    Yonsei Med J; 2016 Mar; 57(2):496-504. PubMed ID: 26847306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of botulinum toxin type A on improvement and dynamic spastic equinus correction in children with cerebral palsy - preliminary results.
    Colovic H; Dimitrijevic L; Stankovic I; Nikolic D; Radovic-Janosevic D; Zivanovic D
    Arch Med Sci; 2014 Oct; 10(5):979-84. PubMed ID: 25395950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exercise intensity levels in children with cerebral palsy while playing with an active video game console.
    Robert M; Ballaz L; Hart R; Lemay M
    Phys Ther; 2013 Aug; 93(8):1084-91. PubMed ID: 23580626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of botulinum toxin therapy on postural control and lower limb intersegmental coordination in children with spastic cerebral palsy.
    Degelaen M; de Borre L; Kerckhofs E; de Meirleir L; Buyl R; Cheron G; Dan B
    Toxins (Basel); 2013 Jan; 5(1):93-105. PubMed ID: 23344454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence-based approach of the use of Botulinum toxin type A (BTX) in cerebral palsy.
    Wong V
    Pediatr Rehabil; 2003; 6(2):85-96. PubMed ID: 14534045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of botulinum toxin guided by electric stimulation on spasticity in ankle plantar flexor of children with cerebral palsy: a randomized trial].
    Xu KS; Yan TB; Mai JN
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):913-7. PubMed ID: 17254459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A French observational study of botulinum toxin use in the management of children with cerebral palsy: BOTULOSCOPE.
    Chaléat-Valayer E; Parratte B; Colin C; Denis A; Oudin S; Bérard C; Bernard JC; Bourg V; Deleplanque B; Dulieu I; Evrard P; Filipetti P; Flurin V; Gallien P; Héron-Long B; Hodgkinson I; Husson I; Jaisson-Hot I; Maupas E; Meurin F; Monnier G; Pérennou D; Pialoux B; Quentin V; Moreau MS; Schneider M; Yelnik A; Marque P
    Eur J Paediatr Neurol; 2011 Sep; 15(5):439-48. PubMed ID: 21745754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botulinum toxin type a neuromuscular blockade in the treatment of equinus foot deformity in cerebral palsy: a multicenter, open-label clinical trial.
    Koman LA; Brashear A; Rosenfeld S; Chambers H; Russman B; Rang M; Root L; Ferrari E; Garcia de Yebenes Prous J; Smith BP; Turkel C; Walcott JM; Molloy PT
    Pediatrics; 2001 Nov; 108(5):1062-71. PubMed ID: 11694682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultrasonographic evaluation of changes in the muscle architecture of the gastrocnemius with botulinum toxin treatment for lower extremity spasticity in children with cerebral palsy.
    Kawano A; Yanagizono T; Kadouchi I; Umezaki T; Chosa E
    J Orthop Sci; 2018 Mar; 23(2):389-393. PubMed ID: 29146092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum toxin with and without casting in ambulant children with spastic diplegia: a clinical and functional assessment.
    Bottos M; Benedetti MG; Salucci P; Gasparroni V; Giannini S
    Dev Med Child Neurol; 2003 Nov; 45(11):758-62. PubMed ID: 14580131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Botulinum toxin a treatment in children with cerebral palsy: its effects on walking and energy expenditure.
    Balaban B; Tok F; Tan AK; Matthews DJ
    Am J Phys Med Rehabil; 2012 Jan; 91(1):53-64. PubMed ID: 22157436
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.